Triple-negative breast cancer (TNBC), which accounts for approximately 15% of all breast cancers, is highly aggressive and characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2)[2]. This evidence concerns the gene ESR1 and breast cancer.